Susceptibility to exudative age-related macular degeneration and three genetic polymorphisms of glutathione s-transferase Z1 (GSTZ1)

European Journal of Ophthalmology

Volumn 22, Issue 3, 2012, Pages 431-435

  Othman, Hasan ^a   Saadat, Iraj ^a   Farvardin Jahromi, Majid ^b   Saadat, Mostafa ^a  

^a SHIRAZ UNIVERSITY   (Iran)

^b SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Age related macular degeneration; GSTZ1; Susceptibility

Indexed keywords

ADULT; AGE; AGED; ARTICLE; CASE CONTROL STUDY; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; GENE; GENE LINKAGE DISEQUILIBRIUM; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GENOTYPE; GSTZ1 GENE; HAPLOTYPE; HUMAN; IRAN; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRIORITY JOURNAL; RETINA MACULA AGE RELATED DEGENERATION;

AGED; CASE-CONTROL STUDIES; EXUDATES AND TRANSUDATES; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; GLUTATHIONE TRANSFERASE; HUMANS; MACULAR DEGENERATION; MALE; MIDDLE AGED; ODDS RATIO; POLYMERASE CHAIN REACTION; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; POLYMORPHISM, SINGLE NUCLEOTIDE; VISUAL ACUITY;

EID: 84863305179     PISSN: 11206721     EISSN: None     Source Type: Journal    
DOI: 10.5301/ejo.5000053     Document Type: Article

References (24)

1. Klein R, Klein BE, Linton KL. Prevalence of age-related maculopathy. The Beaver Dam Eye Study. Ophthalmology 1992; 99: 933-943.
2. Vingerling JR, Dielemans I, Hofman A, et al. The prevalence of age-related maculopathy in the Rotterdam Study. Ophthalmology 1995; 102: 205-210.
3. Yates JR, Moore AT. Genetic susceptibility to age related macular degeneration. J Med Genet 2000; 37: 83-87.
4. Katta S, Kaur I, Chakrabarti S. The molecular genetic basis of age-related macular degeneration: an overview. J Genet 2009; 88: 425-449.
5. Beatty S, Koh H, Phil M, Henson D, Boulton M. The role of oxidative stress in the pathogenesis of age-related macular degeneration. Surv Ophthalmol 2000; 45: 115-134.
6. Zarbin MA. Current concepts in the pathogenesis of agerelated macular degeneration. Arch Ophthalmol 2004; 122: 598-614.
7. Choudhary S, Xiao T, Srivastava S, et al. Toxicity and detoxification of lipid-derived aldehydes in cultured retinal pigmented epithelial cells. Toxicol Appl Pharmacol 2005; 204: 122-134.
8. Kimura K, Isashiki Y, Sonoda S, Kakiuchi-Matsumoto T, Ohba N. Genetic association of manganese superoxide dismutase with exudative age-related macular degeneration. Am J Ophthalmol 2000; 130: 769-773.
9. Oz O, Aras Ates N, Tamer L, Yildirim O, Adigüzel U. Glutathione S-transferase M1, T1, and P1 gene polymorphism in exudative age-related macular degeneration: a preliminary report. Eur J Ophthalmol 2006; 16: 105-110.
10. Güven M, Görgün E, Ünal M, et al. Glutathione S-transferase M1, GSTT1 and GSTP1 genetic polymorphisms and the risk of age-related macular degeneration. Ophthalmic Res 2011; 46: 31-37.
11. Othman H, Gholampour AR, Saadat I, Farvardin-Jahromoi M, Saadat M. Age-related macular degeneration and genetic polymorphisms of glutathione S-transferases M1 (GSTM1) and T1 (GSTT1). Mol Biol Rep Epub 2011 Jun 24.
12. Blackburn AC, Tzeng HF, Anders MW, Board PG. Discovery of a functional polymorphism in human glutathione transferase zeta by expressed sequence tag database analysis. Pharmacogenetics 2000; 10: 49-57.
13. Fang YY, Kashkarov U, Anders MW, Board PG. Polymorphisms in the human glutathione transferase zeta promoter. Pharmacogenet Genomics 2006; 16: 307-313.
14. Blackburn AC, Matthaei KI, Lim C, et al. Deficiency of glutathione transferase zeta causes oxidative stress and activation of antioxidant response pathways. Mol Pharmacol 2006; 69: 650-657.
15. Masoudi M, Saadat I, Omidvari S, Saadat M. Additive effects of genetic variations of xenobiotic detoxification enzymes and DNA repair gene XRCC1 on the susceptibility to breast cancer. Breast Cancer Res Treat 2010; 120: 263-265.
16. Saadat M, Saadat I, Saboori Z, Emad A. Combination of CC16, GSTM1, and GSTT1 genetic polymorphisms is associated with asthma. J Allergy Clin Immunol 2004; 113: 996-998.
17. Saadat M, Mobayen F, Farrashbandi H. Genetic polymorphism of glutathione S-transferase T1: a candidate genetic modifier of individual susceptibility to schizophrenia. Psychiatry Res 2007; 153: 87-91.
18. Mohamadynejad P, Saadat M. Genetic polymorphisms of XRCC1 (at codons 194 and 399) in Shiraz population (Fars province, southern Iran). Mol Biol Rep 2008; 35: 669-672.
19. Rafiee L, Saadat I, Saadat M. Glutathione S-transferase genetic polymorphisms (GSTM1, GSTT1 and GSTO2) in three Iranian populations. Mol Biol Rep 2010; 37: 155-158.
20. Nafissi S, Saadat I, Farrashbandi H, Saadat M. Association between three genetic polymorphisms of glutathione Stransferase Z1 (GSTZ1) and susceptibility to schizophrenia. Psychiatry Res 2011; 187: 314-315.
21. Nafissi S, Saadat I, Saadat M. Genetic polymorphisms of glutathione S-transferase Z1 in an Iranian population. Mol Biol Rep 2011; 38: 3391-3394.
22. Saadat M. Genetic polymorphisms of glutathione S-transferase T1 (GSTT1) and susceptibility to gastric cancer: a meta-analysis. Cancer Sci 2006; 97: 505-509.
23. Saadat M, Ansari-Lari M. Polymorphism of XRCC1 (at codon 399) and susceptibility to breast cancer, a meta-analysis of the literatures. Breast Cancer Res Treat 2009; 115: 137-144.
24. Hu Z, Ma H, Chen F, Wei Q, Shen H. XRCC1 polymorphisms and cancer risk: a meta-analysis of 38 case-control studies. Cancer Epidemiol Biomarkers Prev 2005; 14: 1810-1818.